NCT00674921View on ClinicalTrials.gov

Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda

PHASE4UnknownINTERVENTIONAL
Enrollment

1,650

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
HIV Infections
Interventions
DRUG

cotrimoxazole

cotrimoxazole 800/160 mg once daily as indicated by the start and end times of the specified arms for continued prevention of HIV-related infections

DRUG

Placebo

starch, magnesium stearate, sodium lauryl sulphate

Trial Locations (1)

256

MRC/UVRI Uganda Research Unit on Aids, Entebbe

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

lead

MRC/UVRI and LSHTM Uganda Research Unit

OTHER

NCT00674921 - Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda | Biotech Hunter | Biotech Hunter